ResearcherUniversity of OxfordActive in the last 2 years
Ashley Kieran Clift
Matched on ORCID iD 0000-0002-0061-979X; OpenAlex author ID A5002181117, A5110707229. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2021: 2 papers · 2022: none · 2023: 1 paper · 2024: 1 paper
Papers 4
- Predicting the risk of pancreatic cancer in adults with new-onset diabetes: development and internal-external validation of a clinical risk prediction model. Co-author DOI 10.1038/s41416-024-02693-9↗
- Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal adenocarcinoma (PDAC): a nested case-contr… Co-author DOI 10.1136/gutjnl-2021-326522↗
- OX2: Understanding the pattern of symptoms for pancreatic neuroendocrine neoplasms (PNENs) to improve the early diagnosis of pancreatic cancer: analysis of the… Co-author DOI 10.1101/2021.02.03.21250038↗
- Predicting risk of pancreatic cancer in individuals with new-onset type-2 diabetes in primary care: protocol for the development and validation of a clinical p… First author DOI 10.1101/2021.12.22.21268161↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Carol A. C. Coupland · 4 shared papers, 2021–2024 · strength 0.71
- Paper Predicting the risk of pancreatic cancer in adults with new-onset diabetes: development and internal-external validatio… DOI 10.1038/s41416-024-02693-9↗
- Paper Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal ad… DOI 10.1136/gutjnl-2021-326522↗
- Paper OX2: Understanding the pattern of symptoms for pancreatic neuroendocrine neoplasms (PNENs) to improve the early diagnos… DOI 10.1101/2021.02.03.21250038↗
- Julia Hippisley‐Cox · 4 shared papers, 2021–2024 · strength 0.71
- Paper Predicting the risk of pancreatic cancer in adults with new-onset diabetes: development and internal-external validatio… DOI 10.1038/s41416-024-02693-9↗
- Paper Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal ad… DOI 10.1136/gutjnl-2021-326522↗
- Paper OX2: Understanding the pattern of symptoms for pancreatic neuroendocrine neoplasms (PNENs) to improve the early diagnos… DOI 10.1101/2021.02.03.21250038↗
- Rachael J. M. Bashford-Rogers · 3 shared papers, 2021–2024 · strength 0.54
- Paper Predicting the risk of pancreatic cancer in adults with new-onset diabetes: development and internal-external validatio… DOI 10.1038/s41416-024-02693-9↗
- Paper Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal ad… DOI 10.1136/gutjnl-2021-326522↗
- Paper Predicting risk of pancreatic cancer in individuals with new-onset type-2 diabetes in primary care: protocol for the de… DOI 10.1101/2021.12.22.21268161↗
- Pui San Tan · 3 shared papers, 2021–2024 · strength 0.54
- Paper Predicting the risk of pancreatic cancer in adults with new-onset diabetes: development and internal-external validatio… DOI 10.1038/s41416-024-02693-9↗
- Paper Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal ad… DOI 10.1136/gutjnl-2021-326522↗
- Paper Predicting risk of pancreatic cancer in individuals with new-onset type-2 diabetes in primary care: protocol for the de… DOI 10.1101/2021.12.22.21268161↗
- Shivan Sivakumar · 3 shared papers, 2021–2024 · strength 0.54
- Paper Predicting the risk of pancreatic cancer in adults with new-onset diabetes: development and internal-external validatio… DOI 10.1038/s41416-024-02693-9↗
- Paper Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal ad… DOI 10.1136/gutjnl-2021-326522↗
- Paper Predicting risk of pancreatic cancer in individuals with new-onset type-2 diabetes in primary care: protocol for the de… DOI 10.1101/2021.12.22.21268161↗
- Stephen P. Pereira · 1 shared paper, 2021 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.